Advanced Search
JIANG Lin, KONG Qing-zhi, HU Xian-zhu. Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1431-1433. DOI: 10.3971/j.issn.1000-8578.2011.12.024
Citation: JIANG Lin, KONG Qing-zhi, HU Xian-zhu. Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(12): 1431-1433. DOI: 10.3971/j.issn.1000-8578.2011.12.024
shu

Clinical Analysis of Whole Body Gamma Knife Combined with DP Regimen for Advanced Non-small Cell Lung Cancer

  • 1.Clinical Medical School，Hubei University of Chinese Medicine，Wuhan 430061，China；2.Department of Oncology,Hubei Provincial Corps Hospital of CPAPF;3.Department of Oncology, The Central Hospital of Wuhan

More Information
  • Received Date: February 27, 2011
  • Revised Date: July 12, 2011
    Graphical Abstract
    • Abstract
  • ObjectiveTo observe the short-term curative effects of whole body gamma knife combined with concurrent chemotherapy for treatment of advanced non-small cell lung cancer(NSCLC) . Methods All 120 patients were treated with whole body gamma knife combined with concurrent chemotherapy.Radiation was delivered in 10 to 14 fractions with a cumulated marginal dose ranged 35～45 Gy.DP project were given with whole body gamma knife,28d per cycle.At least 2 cycles were delivered.Clinical effects were evaluated 3 months after whole body gamma knife treatment. Results The total efficacy rate was 85.00% ( 102/120 ) .Acute radiation induced lung injury was 5.83% (7/120)(Ⅰ～Ⅱ) ; acute radiation induced esophagus injury was 4.17% (5/120)( Ⅰ～Ⅱ) ; bone marrow toxicity 12.50% (Ⅲ).In the follow up of 24 months,the survival rates at 6,12 and 24 months were 85.83% (103/120),54.17% (65/120) and 39.17%（47/120）,respectively. Conclusion Whole body gamma knife combined with concurrent chemotherapy is a feasible,safe,and effective method and could be well tolerated in most patients.It is a good treatment for patients with advanced lung cancer and deserves further investigation.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]LI Hongfei, TANG Weizhong, HUANG Qinglu, HUANG Kezeng, CAI Shangkun. Effect of Oxaliplatin on CD44V6, VEGF, survivin, Caspase-3 and Caspase-7 in Dimethylhydrazine-induced Colon Cancer Rats[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 560-563. DOI: 10.3971/j.issn.1000-8578.2015.06.006
    [2]Nie Yanli, Ruan Zhiping, Nan Kejun. Expressions of DR5，caspase-8，caspase-9 and caspase-3 in HepG2 Cell Line Treated with Gemcitabine[J]. Cancer Research on Prevention and Treatment, 2013, 40(02): 134-137. DOI: 10.3971/j.issn.1000-8578.2013.02.003
    [3]DING Hui, LI Xian-ming, GAO Yan, HU Li-xia, YANG Dong, ZHOU Ya-yan, XU Gang. Expression and Significance of HIF-2α and Caspase-3 in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(01): 41-44. DOI: 10.3971/j.issn.1000-8578.2011.01.012
    [4]WANG Feng-qi, ZHAO Wei-ming, ZHANG Cheng, JIN Cheng-jun, ZHANG Zi-jian, ZHONG Zhao-hua, XIU You-cheng. Experimental of Combining Therapy with IL-12 Gene and THP in Bladder Cancer Nude Mice Model[J]. Cancer Research on Prevention and Treatment, 2010, 37(11): 1241-1244. DOI: 10.3971/j.issn.1000-8578.2010.11.008
    [5]WANG Ya-li, WANG Zhong-wei, WANG Xi-jing, JIN Ying-ying. Caspase-3 Gene of Mediating X radiation Induced Apoptosis in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 541-544. DOI: 10.3971/j.issn.1000-8578.2009.07.001
    [6]ZHANG Xiao-Juan, WANG Na, ZHOU Rong-Miao, DONG Xiu-Juan, LI Yan. Correlation of MMP-12 Polymorphism to Risk of Squamous Cell Carcinoma and Gastric Cardiac Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(10): 740-743. DOI: 10.3971/j.issn.1000-8578.2861
    [7]WANG Yan-yan, SONG Xing-fu, CUI Xiang-jun, HUANG Ji. Apoptosis Induced by Artesunate in Human Adenocarcinoma Cell Line A549 Cells Associated with Activation of caspase-9 and caspase-3[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 651-653. DOI: 10.3971/j.issn.1000-8578.2020
    [8]HUANG Wen-fang, YANG Yong-chang, LIU Hua, CHEN Jiang, ZHOU Ding-an. Changes of Caspase-3 and Caspase-9 Activity during the Simvastatin-induced Apoptosis in K562 Cells[J]. Cancer Research on Prevention and Treatment, 2007, 34(01): 39-41. DOI: 10.3971/j.issn.1000-8578.1221
    [9]YE Shu-nan, YANG Shu-hua, YANG Chao, XU Wei-hua. A Tumor-targeted Vector for Interleukin-12 Gene Therapy to Enhance the Anti-osteosarcoma Immunity in Nude Mouse[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 305-307. DOI: 10.3971/j.issn.1000-8578.2424
    [10]YE Shu-nan, YANG Shu-hua, WU Qiang, YANG Cao, LI Jing, XU Wei-hua. Polythylenimine AS A Nonviral Vector for Murine Interleukin-12 Gene Transfer to the Mouse Osteosarcoma Cells[J]. Cancer Research on Prevention and Treatment, 2005, 32(02): 96-98. DOI: 10.3971/j.issn.1000-8578.693

Catalog

    Get Citation
    PDF
    XML
    Article views (2108) PDF downloads (280) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：11640214 Visits today：7563

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return